Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin
Clinical trial NCT03351478 · COMPLETED
Trial details
- NCT number
- NCT03351478
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2019-05-16
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.